封面
市場調查報告書
商品編碼
1705991

腸外營養市場:依營養類型、依病患類型、依應用、依通路、按地區

Parenteral Nutrition Market, By Nutrition Type, By Patient Type, By Application, By Distribution Channel, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 224 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025 年全球腸外營養市場價值估計為 45.543 億美元,預計到 2032 年將達到 69.393 億美元。預計 2025 年至 2032 年期間的年複合成長率(CAGR)為 6.2%。

報告範圍 報告詳細資訊
基準年 2024 2025年的市場規模 45.543億美元
效能數據 2020-2024 預測期 2025-2032
預測期:2025-2032年複合年成長率: 6.20% 2032年價值預測 6,939 百萬美元
數字。 2025年各地區腸外營養市場佔有率(%)
腸外營養市場-IMG1

腸外營養(通常稱為全腸外營養)是透過靜脈(靜脈注射)給予的特殊形式食物的醫學術語。治療的目的是矯正或預防營養不良。腸外營養提供液體營養素,如碳水化合物、蛋白質、脂質、維生素、礦物質和電解質。有些人使用腸外營養,透過放置在胃或小腸中的管子來獲取營養(腸外營養),而其他人則單獨使用腸外營養。當患者的消化器官系統無法透過口腔吸收或耐受足夠量的食物時,可使用腸外營養。在醫院外使用靜脈營養時,稱為家庭腸外營養。家庭腸外營養可能需要持續數週、數月甚至終生。導管感染是腸外營養的常見且嚴重的併發症。腸外營養的其他潛在短期併發症包括血栓、液體和礦物質失衡以及血糖代謝問題。

市場動態:

近年來,由於導致營養不良的慢性病盛行率不斷上升,全球腸外營養市場經歷了顯著成長。當口服或腸內途徑不可行時,腸外營養是指透過靜脈導管將營養素直接輸送到血液中。腸外營養廣泛應用於癌症、胃腸道疾病、肝病和其他慢性疾病的營養不良患者的治療。此外,老年人口的不斷成長,導致消化器官系統較弱、更容易營養不良,這也導致對腸外製劑的需求不斷成長。各市場參與企業正致力於開發創新的腸外營養解決方案,以滿足該病患小組的治療需求。然而,腸外營養的高成本對其廣泛應用構成了重大挑戰。

本研究的主要特點

  • 本報告對全球腸外營養市場進行了詳細分析,並提供了預測期(2025-2032)的市場規模和年複合成長率(CAGR),假設 2024 年為基準年。
  • 它還揭示了各個領域的潛在商機,並解釋了該市場的有吸引力的投資提案矩陣。
  • 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
  • 全球腸外營養市場的主要企業是根據公司亮點、產品系列、關鍵亮點、財務績效和策略等參數進行的分析。
  • 本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
  • 全球腸外營養市場報告迎合了該行業的各個相關人員,例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
  • 相關人員可以透過分析全球腸外營養市場所使用的各種策略矩陣來促進決策。

目錄

第1章 調查目的與前提條件

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章市場動態、法規與趨勢分析

  • 市場動態
    • 主要市場參與者之間的合作增強
    • 缺乏對醫療保健、食品和適當營養的意識
    • 增強型腸外營養解決方案的出現
  • 主要亮點
  • 監管情景
  • 市場趨勢
  • 產品發布/核准
  • PEST分析
  • 波特分析
  • 流行病學
  • 主要市場參與者的新投資
  • 定價分析
  • 合併、收購和合作

4. 全球腸外營養市場-冠狀病毒(COVID-19)大流行的影響

  • COVID-19流行病學
  • 供需側分析
  • 經濟影響

5. 全球腸外營養市場(依營養類型),2020-2032 年

  • 碳水化合物
  • 脂質乳劑
  • 維生素和微量礦物質
  • 蛋白質
  • 其他(胺基酸等)

6. 2020 年至 2032 年按病患類型分類的全球腸外營養市場

  • 嬰兒
  • 成人
  • 老年人

7. 全球腸外營養市場(按應用)2020-2032

  • 糖尿病
  • 腎衰竭
  • 肌少症
  • 癌症
  • 其他(消化系統疾病、METABOLIC INC.症候群等)

8. 全球腸外營養市場(依通路分類),2020-2032 年

  • 醫院藥房
  • 零售藥局
  • 網路藥局

9. 全球腸外營養市場(按地區分類),2020-2032 年

  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東
  • 非洲

第10章 競爭格局

  • 公司簡介
    • AbbVie Inc.
    • Danone
    • Fresenius Kabi AG
    • GENTAG, Inc.
    • GSK plc.
    • Nestle SA
    • Nutricia
    • Sun Pharmaceutical Industries Ltd.
    • Pfizer Inc.
    • Sanofi
    • VIRIDIAN SA

第 11 章 章節

  • 參考
  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI4804

Global Parenteral Nutrition Market is estimated to be valued at USD 4,554.3 Mn in 2025 and is expected to reach USD 6,939. Mn by 2032, growing at a compound annual growth rate (CAGR) of 6.2% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 4,554.3 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 6.20% 2032 Value Projection: USD 6,939. Mn
Figure. Parenteral Nutrition Market Share (%), By Region 2025
Parenteral Nutrition Market - IMG1

Parenteral nutrition, often called total parenteral nutrition, is the medical term for infusing a specialized form of food through a vein (intravenously). The goal of the treatment is to correct or prevent malnutrition. Parenteral nutrition provides liquid nutrients, including carbohydrates, proteins, fats, vitamins, minerals and electrolytes. Some people use parenteral nutrition to supplement feeding through a tube placed into the stomach or small bowel (enteral nutrition), and others use it by itself. People whose digestive systems either can't absorb or can't tolerate adequate food eaten by mouth use parenteral nutrition. When used outside the hospital, intravenous feeding is called home parenteral nutrition. Using home parenteral nutrition may be necessary for weeks or months, or in some cases for life. Catheter infection is a common and serious complication of parenteral nutrition. Other potential short-term complications of parenteral nutrition include blood clots, fluid and mineral imbalances, and problems with blood sugar metabolism.

Market Dynamics:

The global parenteral nutrition market has been witnessing significant growth in the recent past owing to the rising prevalence of chronic diseases inducing malnutrition. Parenteral nutrition entails delivering nutrients directly into the bloodstream through an intravenous catheter when oral or enteral routes are not feasible. It finds wide application in treating malnourished patients suffering from cancer, gastrointestinal disorders, liver diseases, and other chronic conditions. Furthermore, the growing geriatric population who are more susceptible to malnutrition due to weak digestive system has also contributed to the rising demand for parenteral formulations. Various market players are engaged in developing innovative parenteral nutrition solutions to meet the treatment demands of such patient groups. However, high costs associated with parenteral feeding remains a major challenge for widespread adoption.

Key features of the study:

  • This report provides an in-depth analysis of the global parenteral nutrition market and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global parenteral nutrition market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include global parenteral nutrition market include AbbVie Inc., Danone, Fresenius Kabi AG, GENTAG, Inc., GSK plc., Nestle SA, Nutricia, Sun Pharmaceutical Industries Ltd, Pfizer Inc., Sanofi, Otsuka Holdings Co., Ltd., and Otsuka Holdings Co., Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global parenteral nutrition market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global parenteral nutrition market.

Detailed Segmentation:

  • Global Parenteral Nutrition Market, By Nutrition Type
    • Carbohydrates
    • Lipid Emulsion
    • Vitamins and Trace Minerals
    • Proteins
    • Others (Amino acids, etc.)
  • Global Parenteral Nutrition Market, By Patient Type
    • Infants
    • Adults
    • Geriatric
  • Global Parenteral Nutrition Market, By Application
    • Diabetes
    • Renal Failures
    • Obesity
    • Sarcopenia
    • Cancer
    • Others (Digestive disorders, Metabolic Syndromes, etc.)
  • Global Parenteral Nutrition Market, By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Parenteral Nutrition Market, By Region
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles
    • AbbVie Inc.
    • Danone
    • Fresenius Kabi AG
    • GENTAG, Inc.
    • GSK plc.
    • Nestle SA
    • Nutricia
    • Sun Pharmaceutical Industries Ltd.
    • Pfizer Inc.
    • Sanofi
    • VIRIDIAN SA

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Nutrition Type
    • Market Snippet, By Patient Type
    • Market Snippet, By Application
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increasing collaborations by key market players
    • Lack of awareness regarding healthcare, diet, and proper nutrition
    • Emergence of enhanced parenteral nutrition solutions
  • Key Highlights
  • Regulatory Scenario
  • Market Trends
  • Product Launch/Approval
  • PEST Analysis
  • PORTER's Analysis
  • Epidemiology
  • New Investments by Major Market Players
  • Pricing Analysis
  • Mergers, Acquisitions, and Collaborations

4. Global Parenteral Nutrition Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Parenteral Nutrition Market, By Nutrition Type, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Carbohydrates
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Lipid Emulsion
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Vitamins and Trace Minerals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Proteins
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Others (Amino acids, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)

6. Global Parenteral Nutrition Market, By Patient Type, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Infants
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Adults
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Geriatric
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)

7. Global Parenteral Nutrition Market, By Application, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Diabetes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Renal Failures
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Sarcopenia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Others (Digestive disorders, Metabolic Syndromes, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)

8. Global Parenteral Nutrition Market, By Distribution Channel, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)

9. Global Parenteral Nutrition Market, By Region, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2021 -2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Nutrition Type, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Nutrition Type, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Nutrition Type, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Nutrition Type, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Nutrition Type, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Nutrition Type, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Mn)
      • North Africa
      • Central Africa
      • South Africa

10. Competitive Landscape

  • Company Profile
    • AbbVie Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Danone
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Fresenius Kabi AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • GENTAG, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • GSK plc.
    • Nestle SA
    • Nutricia
    • Sun Pharmaceutical Industries Ltd.
    • Pfizer Inc.
    • Sanofi
    • VIRIDIAN SA
  • Analyst Views

11. Section

  • References
  • Research Methodology
  • About us